Mather Group LLC. Sells 70 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Mather Group LLC. trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.8% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,138 shares of the company’s stock after selling 70 shares during the period. Mather Group LLC.’s holdings in HCA Healthcare were worth $342,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Legacy Investment Solutions LLC acquired a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $39,000. Capital Performance Advisors LLP acquired a new position in shares of HCA Healthcare during the third quarter worth approximately $41,000. Canoe Financial LP bought a new stake in HCA Healthcare during the 3rd quarter valued at $41,000. Northwest Investment Counselors LLC acquired a new position in shares of HCA Healthcare during the third quarter valued at about $44,000. Finally, Friedenthal Financial bought a new position in HCA Healthcare in the 3rd quarter valued at about $50,000. 62.73% of the stock is owned by institutional investors.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares of the company’s stock, valued at $2,415,579. The trade was a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

HCA Healthcare Stock Down 3.7 %

Shares of NYSE HCA opened at $324.33 on Friday. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $417.14. The company has a market cap of $82.15 billion, a P/E ratio of 14.76, a P/E/G ratio of 1.13 and a beta of 1.64. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. The business has a 50-day simple moving average of $313.88 and a two-hundred day simple moving average of $353.57.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the business posted $5.90 earnings per share. Research analysts anticipate that HCA Healthcare, Inc. will post 24.89 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 annualized dividend and a yield of 0.89%. HCA Healthcare’s payout ratio is presently 13.11%.

Wall Street Analyst Weigh In

HCA has been the topic of several analyst reports. Bank of America cut their target price on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research report on Monday, January 27th. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their target price for the company from $400.00 to $320.00 in a report on Monday, November 25th. Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. JPMorgan Chase & Co. reiterated a “neutral” rating and set a $380.00 price target on shares of HCA Healthcare in a report on Tuesday, December 17th. Finally, TD Cowen cut their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.